Pancreatic ductal adenocarcinoma and transcription factors: Role of c-Myc

被引:46
|
作者
Skoudy A. [1 ]
Hernández-Muñoz I. [1 ]
Navarro P. [1 ]
机构
[1] Cancer Research Programme, IMIM (Institut de Recerca Hospital Del Mar), Barcelona 08003
关键词
c-Myc; Ela-myc transgenic mouse; Pancreatic development; Pancreatic ductal adenocarcinoma; Transcription factor;
D O I
10.1007/s12029-011-9258-0
中图分类号
学科分类号
摘要
Introduction: Deregulated expression/activation of transcription factors is a key event in the establishment and progression of human cancer. Furthermore, most oncogenic signaling pathways converge on sets of transcription factors that ultimately control gene expression patterns resulting in cancer development, progression, and metastasis. Methods: Ductal pancreatic adenocarcinoma (PDA) is the main type of pancreatic cancer and the fourth leading cause of cancer mortality in the Western world. The early stage of the disease is characterized by pancreatic intraepithelial neoplasia lesions bearing mutations in the K-RAS proto-oncogene, which progress to malignant PDA by accumulating additional mutations in the tumor suppressor gene CDKN2A (p16) and in SMAD4 and TP53 transcription factors. The involvement of other signaling pathways in PDA development and progression is an active area of research which may help to clarify the critical steps of this devastating disease. Results: In this regard, several in vitro and in vivo data have demonstrated the contribution of the transcription factor c-Myc to pancreatic carcinogenesis although the molecular mechanisms are poorly understood. c-Myc is a proto-oncogene which has a pivotal function in growth control, differentiation and apoptosis and is known to act as a downstream transcriptional effector of many signaling pathways involved in these processes. It is regulated at multiple levels and its abnormal expression contributes to the genesis of many human tumors. Conclusions: This review focuses on the role of c-Myc in pancreatic embryonic development and homeostasis as well as its involvement on pancreatic tumorigenesis. Evidences showing that c-Myc function is highly dose and cell context dependent, together with its recently demonstrated ability to reprogram somatic cells towards a pluripotent stem cell-like state, indicate that the role of c-Myc in pancreas pathophysiology might have been previously underscored. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:76 / 84
页数:8
相关论文
共 50 条
  • [41] The Role of Histone Deacetylases in Pancreatic Ductal Adenocarcinoma
    Mousavi, F.
    Pin, C. L.
    PANCREAS, 2021, 50 (07) : 1084 - 1084
  • [42] C-myc oncogene amplification in ductal carcinoma in situ of the breast
    Aulmann, S
    Bentz, M
    Sinn, HP
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 74 (01) : 25 - 31
  • [43] Nuclear exclusion of the transcription factors c-Myc and Max during programmed cell death
    Petrs-Silva, H
    Linden, R
    Chiarini, LB
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 22A - 22A
  • [44] Mechanisms of transcriptional activation of the stimulator of interferon genes by transcription factors CREB and c-Myc
    Wang, Yan-Yan
    Jin, Rui
    Zhou, Guo-Ping
    Xu, Hua-Guo
    ONCOTARGET, 2016, 7 (51): : 85049 - 85057
  • [45] Phosphorylated protein factors of transcription regulate an expression of the human c-myc gene.
    Itkes, AV
    Imamova, LR
    FASEB JOURNAL, 1998, 12 (04): : A131 - A131
  • [46] A REPRESSOR OF C-MYC TRANSCRIPTION IS FOUND SPECIFICALLY IN PLASMACYTOMAS
    KAKKIS, E
    RIGGS, K
    CALAME, K
    CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1988, 141 : 231 - 237
  • [47] MODULATION OF C-MYC TRANSCRIPTION BY TRIPLE HELIX FORMATION
    POSTEL, EH
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 660 : 57 - 63
  • [48] Function of the c-Myc oncoprotein in chromatin remodeling and transcription
    Amati, B
    Frank, SR
    Donjerkovic, D
    Taubert, S
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1471 (03): : M135 - M145
  • [49] Role of oncogenic transcription factor c-Myc in cell cycle regulation, apoptosis and metabolism
    Dang, CV
    Lewis, BC
    JOURNAL OF BIOMEDICAL SCIENCE, 1997, 4 (06) : 269 - 278
  • [50] REGULATION OF TRANSCRIPTION FACTORS C-MYC, MAX, AND C-MYB BY CASEIN KINASE-II
    BOUSSET, K
    OELGESCHLAGER, MHH
    HENRIKSSON, M
    SCHREEK, S
    BURKHARDT, H
    LITCHFIELD, DW
    LUSCHERFIRZLAFF, JM
    LUSCHER, B
    CELLULAR & MOLECULAR BIOLOGY RESEARCH, 1994, 40 (5-6) : 501 - 511